Grakova, E. V., Kopeva, K. V., Teplyakov, A. T., Soldatenko, M. V., Suslova, T. E., & Kalyuzhin, V. V. (2022). Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction. Бюллетень сибирской медицины, 21(1), 35-46. https://doi.org/10.20538/1682-0363-2022-1-35-46
Chicago Style (17th ed.) CitationGrakova, E. V., K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, and V. V. Kalyuzhin. "Effect of β-blocker Therapy on the Level Soluble ST2 Protein in the Blood Serum in Patients with Heart Failure with Preserved and Mildly Reduced Ejection Fraction." Бюллетень сибирской медицины 21, no. 1 (2022): 35-46. https://doi.org/10.20538/1682-0363-2022-1-35-46.
MLA (9th ed.) CitationGrakova, E. V., et al. "Effect of β-blocker Therapy on the Level Soluble ST2 Protein in the Blood Serum in Patients with Heart Failure with Preserved and Mildly Reduced Ejection Fraction." Бюллетень сибирской медицины, vol. 21, no. 1, 2022, pp. 35-46, https://doi.org/10.20538/1682-0363-2022-1-35-46.